Literature DB >> 15702608

Type I error probabilities based on design-stage strategies with applications to noninferiority trials.

Mark Rothmann1.   

Abstract

When testing the equality of means from two different populations, a t-test or large sample normal test tend to be performed. For these tests, when the sample size or design for the second sample is dependent on the results of the first sample, the type I error probability is altered for each specific possibility in the null hypothesis. We will examine the impact on the type I error probabilities for two confidence interval procedures and procedures using test statistics when the design for the second sample or experiment is dependent on the results from the first sample or experiment (or series of experiments). Ways for controlling a desired maximum type I error probability or a desired type I error rate will be discussed. Results are applied to the setting of noninferiority comparisons in active controlled trials where the use of a placebo is unethical.

Entities:  

Mesh:

Year:  2005        PMID: 15702608     DOI: 10.1081/bip-200040847

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  3 in total

1.  A simulation study evaluating bio-creep risk in serial non-inferiority clinical trials for preservation of effect.

Authors:  K Odem-Davis; T R Fleming
Journal:  Stat Biopharm Res       Date:  2015-01-01       Impact factor: 1.452

2.  On robustness of noninferiority clinical trial designs against bias, variability, and nonconstancy.

Authors:  Qing Liu; Yulan Li; Katherine Odem-Davis
Journal:  J Biopharm Stat       Date:  2015       Impact factor: 1.051

3.  Adjusting for unknown bias in non-inferiority clinical trials.

Authors:  Katherine Odem-Davis; Thomas R Fleming
Journal:  Stat Biopharm Res       Date:  2013-01-01       Impact factor: 1.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.